Vitamin D: The Hormone Masquerading as a Vitamin
Vitamin D is technically a misnomer — it is not a traditional vitamin (a nutrient we cannot make ourselves) but a prohormone that the body synthesizes in skin upon ultraviolet-B radiation exposure. The liver converts vitamin D3 to 25-hydroxyvitamin D (25(OH)D, the circulating storage form measured by blood tests), which is then activated by the kidneys to 1,25-dihydroxyvitamin D (calcitriol, the biologically active hormone). Vitamin D receptors are found in virtually every tissue in the human body — not just bone, where vitamin D’s calcium-regulating role is best known, but in the immune system, brain, heart, muscles, gut, and pancreas — reflecting an evolutionary heritage of near-constant sunlight exposure.
The scope of vitamin D’s biological roles has expanded dramatically as research has identified vitamin D response elements in over 2,700 genes. In the immune system, calcitriol directly activates T cells and natural killer cells, induces production of antimicrobial peptides (cathelicidins and defensins that directly kill bacteria, viruses, and fungi), and modulates the inflammatory response. This is why vitamin D deficiency consistently predicts increased susceptibility to respiratory infections — and why several systematic reviews found vitamin D supplementation significantly reduces acute respiratory infection risk (particularly in those with deficient baseline levels). In the cardiovascular system, vitamin D regulates renin (the enzyme initiating the blood pressure cascade), cardiac muscle function, and arterial stiffness. In the pancreas, vitamin D receptors on beta cells regulate insulin secretion and glucose metabolism.
The prevalence of vitamin D deficiency is staggering: an estimated 1 billion people globally have deficient or insufficient levels (below 20 ng/mL or 30 ng/mL, respectively). In the United States, 42% of adults are deficient; among Black Americans (darker skin requiring more UV exposure for the same D3 production), the rate approaches 80%. In Northern Europe in winter, deficiency is nearly universal without supplementation. The epidemic of vitamin D deficiency reflects modern indoor living, sunscreen use, and diets low in vitamin D-containing foods — a radical departure from the sunlight-rich environment in which human vitamin D metabolism evolved.
KEY TAKEAWAYS
- Vitamin D receptors are found in virtually every tissue — it influences over 2,700 genes
- 1 billion people globally are vitamin D deficient, including 42% of U.S. adults
- Optimal serum levels are 40-60 ng/mL; most people need supplementation to achieve this
- Vitamin K2 is essential alongside vitamin D3 to direct calcium to bones rather than arteries
What Vitamin D Deficiency Does to Your Health
Bone health is the classical domain of vitamin D: deficiency causes rickets in children (soft, deformed bones), osteomalacia in adults (painful bone softening), and dramatically accelerates osteoporosis risk in older adults. Vitamin D is required for calcium absorption in the gut — deficiency reduces intestinal calcium absorption by 50% — and for direct bone mineralization. Without adequate vitamin D, the parathyroid gland upregulates PTH (parathyroid hormone) to pull calcium from bones into the bloodstream, accelerating bone resorption. Fracture risk in older adults is substantially elevated with vitamin D deficiency and is reduced by supplementation, particularly when combined with calcium and resistance exercise.
Cancer prevention: observational data consistently shows inverse associations between vitamin D status and risk of colorectal, breast, prostate, and pancreatic cancer. The VITAL RCT (2022 follow-up analysis) found that vitamin D3 supplementation at 2000 IU daily for 5 years reduced advanced cancer (metastatic cancer and cancer death) by 17%, with stronger effects in non-obese participants. While primary cancer incidence was not significantly reduced, the reduction in cancer lethality is clinically important. Mechanistic explanations: vitamin D induces differentiation and apoptosis in cancer cells, inhibits angiogenesis (cancer’s blood supply), and reduces the inflammatory tumor microenvironment.
Immune function: the COVID-19 pandemic drew global attention to vitamin D’s immune role. Multiple observational studies found that vitamin D deficiency was associated with higher COVID-19 severity and mortality (with some studies finding 3-5 fold increased risk of ICU admission in deficient patients). While subsequent RCTs showed mixed results for supplementation in active COVID-19 (likely because short-term supplementation cannot quickly correct functional deficiency), the prepandemic evidence for vitamin D in reducing respiratory infection susceptibility remains robust. A 2017 BMJ meta-analysis of 25 RCTs found that vitamin D supplementation reduced acute respiratory infections by 12% overall and by 70% in participants with severe baseline deficiency.
Mood and mental health: vitamin D receptors in the hippocampus and prefrontal cortex, combined with vitamin D’s role in serotonin and dopamine synthesis, create a clear mechanistic basis for associations between deficiency and depression. Epidemiological studies show consistent inverse associations between vitamin D status and depression risk. RCTs show mixed results, with the most consistent benefits in deficient populations and in those with seasonal affective disorder (SAD) — whose winter-related symptoms closely parallel the declining vitamin D levels in that season. For many people with SAD, optimizing vitamin D to 50-60 ng/mL provides meaningful symptomatic benefit alongside light therapy.
Optimal Testing, Dosing, and Supplementation Protocol
Testing: request a 25-hydroxyvitamin D (25(OH)D) serum test — this is the standard clinical measure. Results interpretation: below 20 ng/mL = deficient; 20-30 ng/mL = insufficient; 30-40 ng/mL = adequate for basic bone health; 40-60 ng/mL = optimal for most health benefits (the range most research suggests is ideal); above 80 ng/mL = potentially excessive; above 150 ng/mL = toxic. Most people supplementing without testing land around 30-40 ng/mL, which is adequate but suboptimal. Testing enables precise titration. Testing should be done in late winter or early spring (when levels are typically at their seasonal nadir) for the most clinically useful baseline.
Supplementation dosing: the RDA for vitamin D (600-800 IU for adults) is widely considered insufficient to achieve optimal serum levels. To reach 40-60 ng/mL from a baseline of 20-25 ng/mL, most adults require 2000-5000 IU of vitamin D3 (cholecalciferol — more bioavailable than D2/ergocalciferol) daily. Obese individuals, older adults, and people with malabsorption conditions need higher doses (3000-6000 IU) due to impaired conversion efficiency. Take vitamin D3 with the largest meal of the day (fat-soluble vitamins are absorbed with dietary fat). Some people use weekly “loading” doses (50,000 IU once weekly for 8-12 weeks) under medical supervision to rapidly correct deficiency, then maintenance doses.
The vitamin D-K2 co-factor: vitamin K2 (menaquinone MK-7 from natto and certain cheeses, or MK-4 from animal products) works synergistically with vitamin D to direct calcium into bones rather than into arterial walls. Vitamin D increases intestinal calcium absorption; without K2’s activation of matrix Gla protein (MGP) and osteocalcin, the absorbed calcium may deposit in soft tissues and arteries (a potential concern with higher-dose vitamin D supplementation). Most vitamin D experts now recommend co-supplementing with 100-200 mcg of vitamin K2 (MK-7 form) when taking vitamin D3 at doses of 2000 IU+. The combination has the best evidence for both bone density and cardiovascular safety.
Sunlight optimization: 15-30 minutes of midday sun exposure on arms and legs (without sunscreen) can produce 10,000-20,000 IU of vitamin D3 in light-skinned individuals — far more than supplementation typically provides. However, this is only possible when the sun is high enough in the sky (UV Index ≥ 3), which in northern latitudes (above 37° north) doesn’t occur from approximately November through March. For people at lower latitudes year-round, regular moderate sun exposure is a legitimate strategy, but must be balanced against skin cancer risk. The safest approach: optimize supplementation year-round, and allow incidental sun exposure without being reliant on it for vitamin D status.